Evaluation of uro-oncological surgical treatment during the Sars-CoV-2 pandemic in a Brazilian tertiary oncology institution, the new world epicenter
- PMID: 33146983
- PMCID: PMC7857743
- DOI: 10.1590/S1677-5538.IBJU.2020.0479
Evaluation of uro-oncological surgical treatment during the Sars-CoV-2 pandemic in a Brazilian tertiary oncology institution, the new world epicenter
Abstract
Introduction: The rapid spread of coronavirus disease 2019 (COVID-19) has dramatic effects on individuals and health care systems. In our institute, a tertiary oncologic public hospital with high surgical volume, we prioritize maintaining cancer treatment as well as possible. The aim of this study is to evaluate if uro-oncological surgeries at pandemic are safe.
Materials and methods: We evaluated patients who underwent uro-oncological procedures. Epidemiological data, information on COVID-19 infection related to surgery and clinical characteristics of non-survival operative patients with COVID-19 infections were analyzed.
Results: From 213 patients analyzed, Covid-19 symptoms were noticed in 8 patients at preoperative process or at hospital admission postponing operation; 161 patients were submitted to elective surgery and 44 to emergency surgery. From patients submitted to elective surgeries, we had 1 patient with laboratory confirmation of COVID-19 (0,6%), with mild symptoms and quick discharge. From the urgencies group, we had 6(13%)patients tested positive; 5 were taken to ICU with 4 deaths.
Conclusion: Elective uro-oncological procedures at the COVID-19 epidemic period in a COVID-19-free Institute are safe, and patients who need urgent procedures, with a long period of hospitalization, need special care to avoid COVID-19 infection and its outcomes.
Keywords: Oncology Service, Hospital; COVID-19 [Supplementary Concept]; Urologic Neoplasms.
Copyright® by the International Brazilian Journal of Urology.
Conflict of interest statement
None declared.
Comment in
-
Urological tumors treatment in Brazil during the SARS-Cov-2 outbrake.Int Braz J Urol. 2021 Mar-Apr;47(2):386-387. doi: 10.1590/S1677-5538.IBJU.2020.0479.1. Int Braz J Urol. 2021. PMID: 33284540 Free PMC article. No abstract available.
Similar articles
-
How uro-oncology has been affected by COVID-19 emergency? Data from Piedmont/Valle d'Aosta Oncological Network, Italy.Urologia. 2021 Feb;88(1):3-8. doi: 10.1177/0391560320946186. Urologia. 2021. PMID: 33632087 Free PMC article.
-
The Impact of the COVID-19 Pandemic on Urology Practice in Indonesia: A Nationwide Survey.Urol J. 2020 Nov 4;17(6):677-679. doi: 10.22037/uj.v16i7.6459. Urol J. 2020. PMID: 33159316
-
Surgery for non-Covid-19 patients during the pandemic.PLoS One. 2020 Oct 23;15(10):e0241331. doi: 10.1371/journal.pone.0241331. eCollection 2020. PLoS One. 2020. PMID: 33095834 Free PMC article.
-
Endourology and Benign Prostatic Hyperplasia in COVID-19 Pandemic.Int Braz J Urol. 2020 Jul;46(suppl.1):34-38. doi: 10.1590/S1677-5538.IBJU.2020.S104. Int Braz J Urol. 2020. PMID: 32550701 Free PMC article. Review.
-
Review of COVID-19 Outcomes in Surgical Patients.Am Surg. 2020 Jul;86(7):741-745. doi: 10.1177/0003134820934395. Epub 2020 Jul 15. Am Surg. 2020. PMID: 32683945 Review.
Cited by
-
Urological complications of COVID-19: a systematic review.Int Braz J Urol. 2023 Jan-Feb;49(1):24-40. doi: 10.1590/S1677-5538.IBJU.2022.0281. Int Braz J Urol. 2023. PMID: 36512453 Free PMC article.
-
Urological tumors treatment in Brazil during the SARS-Cov-2 outbrake.Int Braz J Urol. 2021 Mar-Apr;47(2):386-387. doi: 10.1590/S1677-5538.IBJU.2020.0479.1. Int Braz J Urol. 2021. PMID: 33284540 Free PMC article. No abstract available.
-
International Brazilian Journal of Urology Is the Official Information Journal of the American Confederation of Urology - CAU.Int Braz J Urol. 2021 Mar-Apr;47(2):229-231. doi: 10.1590/S1677-5538.IBJU.2021.02.01. Int Braz J Urol. 2021. PMID: 33284530 Free PMC article. No abstract available.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous